1. Aiuti, F., Businco, L., Rossi, P., and Quinti, I., 1980, Response to thymopoietin pentapeptide in patients with Di George syndrome, Lancet 1:91–95.
2. Amor, B., Dougados, M., Mery, C., de Gery, A., Kahan, A., Dardenne, M., Chatenoud, L., Simon-Lavoine, N., Choay, J., and Bach, J. E., 1987, Nonathymulin in rheumatoid arthritis: Double-blind placebo-controlled trials, in: Immune Regulation by Characterized Polypeptides, UCLA Symposia on Molecular and Cellular Biology, Volume 41 (G. Goldstein, J. E Bach, and H. Wigzell, eds.), Alan R. Liss Inc, New York, pp. 231–244.
3. Audhya, T., Heavner, G. A., Kroon, D. J., and Goldstein, G., 1984, Cooperativity of thymopoietin 32-36 (the active site) and thymopoietin 38-45 in receptor binding. Regul. Pept. 9:155–161.
4. Bach, J. E., 1983, Thymic hormones, in: Clinical Immunology and Allergy (J. F. Bach, ed.), W.B. Saunders, Philadelphia, pp. 3, 133-141.
5. Bach, J. F., 1987, The role of thymic hormones in T-cell differentiation: An overview, in: Immune Regulation by Characterized Polypeptides, UCLA Symposia on Molecular and Cellular Biology, New Series, Volume 41 (G. Goldstein, J. E Bach, and H. Wigzell, eds.), Alan R. Liss Inc, New York, pp. 245–258.